Skip to content
CompanySight
Sign in
Company No. 09793586 · Incorporated 24 Sep 2015

Advanz Pharma UK and Ireland Limited

Registered name: ADVANZ PHARMA UK AND IRELAND LIMITED

Part of Mercury Pharma Group Limited group

Advanz Pharma UK and Ireland Limited made £14.1m revenue and £419k profit in the year to 31 Dec 2023.

Advanz Pharma UK and Ireland Limited’s revenue grew 16% to £14.1m in the year to 31 Dec 2023, with £419k profit and 13 employees. The company is classified under “wholesale of pharmaceutical goods” and is based in London; we hold 2 years of its filed accounts.

Full P&L filedSection G · Wholesale and retail trade; repair of motor vehiclesSIC 46460Wholesale of pharmaceutical goods
Status
Active
Location
London, London
Age
11 yrs · since 2015
Type
Private Limited Company

Part of a group. The filing indicates this company sits within a group structure, so its results may depend on intra-group trading and it may be hard to replicate independently.

Latest accounts · year to 31 Dec 2023

Key figures

Capital-lightDoing more with less
Revenue
£14.1m
Growth ▲15.7%
Profit
£419k
Growth ▼50.4%
Profit margin
3%
Gross 97.1%
Employees
13
Change ▼7.1%
Profit / employee
£32.2k
Revenue/employee £1.1m
Profitable streak
2yrs
Consecutive profitable years in our data

Badges are automated estimates derived from the filed figures — not statements of fact about the company.

2 filed years

Financial history

Multi-year financials, oldest to newest
Year to31 Dec 202231 Dec 2023
DisclosureFull P&LFull P&L
Profit & loss
Revenue (turnover)£12.2m£14.1m
Cost of sales£5.4m£411k
Gross profit£6.8m£13.7m
Operating profit£845k£448k
Profit before tax£845k£448k
Profit after tax£845k£419k
Profit (best available)£845k£419k
Employees (average)1413
Ratios
Profit margin6.9%3%
Gross margin56%97.1%
Revenue per employee£872k£1.1m
Profit per employee£60.3k£32.2k
Growth (year on year)
Revenue growth—▲15.7%
Profit growth—▼50.4%
Headcount growth—▼7.1%
Balance sheet — indirect signals, not revenue
Cash at bank£6.8m£1.8m
Net assets£4.7m£5.1m
Fixed assets£0£0
Current assets£37.6m£35.8m
Debtors£5.1m£4.9m
Deferred income£1.6m£1.9m
SourceFullAccounts · bulk data Sep 2024FullAccounts · bulk data Sep 2024
Derived from the latest filing

How the business works

Profit margin
3%
Profit ÷ revenue.
Gross margin
97.1%
Gross profit ÷ revenue. High for software and services.
Revenue per employee
£1.1m
Revenue ÷ average employees.
Profit per employee
£32.2k
Profit ÷ average employees.
Cash conversion
—
Cash generated from operations ÷ operating profit. Needs a cash-flow statement.
Fixed assets ÷ revenue
0%
Capital intensity. Low = capital-light, cheaper to start.
Deferred income ÷ revenue
13.4%
Customers paying upfront (subscriptions, deposits). Approximate when combined with accruals.
Debtors ÷ revenue
34.9%
Money owed by customers. Low = customers pay quickly.
Indirect — not revenue

Balance-sheet signals

Year-on-year changes in filed balance-sheet items. They can hint at momentum (or investment) but are not revenue or profit and must not be read as such.

Net assets
▲9%
Now £5.1m
Cash at bank
▼73%
Now £1.8m
Headcount
▼7%
Now 13
Deferred income
▲15%
Now £1.9m
Fixed assets
—
Now £0

Deferred income is reported together with accruals in this filing (“accruals and deferred income”), so it is an approximate signal only.

Corporate ownership

Group structure

Ownership chain

  1. Mercury Pharma Group Limitedultimate parent75–100%
  2. Advanz Pharma UK and Ireland Limitedthis company

Bands show the share of ownership each company holds in the one below it.

Sister companies (8)

From the Persons with Significant Control register (corporate controllers only).

Same industry, similar size

Similar profitable businesses

Industry benchmarks →

Sources

Companies House profile Filing history & original accounts

Latest figures from FullAccounts for the year to 31 Dec 2023 (profit £419k), from the Companies House accounts bulk data published Sep 2024. Spotted an error? Request a correction.

Contains public sector information from Companies House licensed under the Open Government Licence v3.0. Data from Companies House, © Crown copyright. View the licence.